Pancreatic Cancer Research

ResearcherRegional Centre for BiotechnologyActive in the last 2 years

Deepti Parida

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5068986054. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Probiotics Mitigate High-cholesterol Diet-driven Fatty Liver and Pancreatic Cancer by Restoring Macrophage Homeostasis. Co-author DOI 10.1016/j.jcmgh.2025.101644↗
  2. Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome. Co-author DOI 10.1007/s00262-023-03562-9↗
  3. Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis. Co-author DOI 10.1038/s41374-021-00690-7↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shantibhusan Senapati · 3 shared papers, 2022–2026 · strength 0.61
  2. Voddu Suresh · 2 shared papers, 2022–2026 · strength 0.44
  3. Debasish Mohapatra · 2 shared papers, 2022–2023 · strength 0.33
  4. Aliva Prity Minz · 2 shared papers, 2022–2023 · strength 0.33
  5. Madhuri Dutta · 1 shared paper, 2023 · strength 0.18
  6. Biswajit Das · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.